Bousser, M G <br/><br/>
The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.  [electronic resource] 

 -  Cerebrovascular diseases (Basel, Switzerland)  2009 
 - 608-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1421-9786 
<br/><br/><label>Standard No.: </label>10.1159/000216835  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Activities of Daily Living<br/>Aged<br/>Aspirin--therapeutic use<br/>Cognition--physiology<br/>Diabetes Complications--complications<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Hypertension--complications<br/>International Cooperation<br/>Ischemic Attack, Transient--epidemiology<br/>Male<br/>Middle Aged<br/>Naphthalenes--therapeutic use<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Propionates--therapeutic use<br/>Receptors, Thromboxane--antagonists & inhibitors<br/>Risk Factors<br/>Secondary Prevention<br/>Severity of Illness Index<br/>Stroke--epidemiology